Edition #3 November 2023
View in browser

Edition #3 | November 2023 

A message from our Senior Conference Producer

The women’s health landscape has taken a notable shift in its approach towards growth amid a challenging quarter, ramping up its rhetoric that investing, innovating and prioritizing women’s health makes economic sense in order to move the needle. With the market in a state of evolving maturity, it’s clear that women’s health is not immune to the challenges facing the broader healthcare landscape. Despite this, there is much to look forward to in an industry that continues to highlight the economic impact of championing women’s health, demonstrating that the market size estimate of $63.02 billion USD by 2030 is certainly within reach. In thinking about the business case for women’s health, a theme - or rather a call-to-action - spoken about widely over the past few months, it’s important to adopt a multi-pronged approach when putting forward the ‘case’. 

 

The World Economic Forum has outlined that ‘an estimated $300 million investment into research focused on women could yield a $13 billion economic return and lead to reduced healthcare costs, better quality of life, and years of productivity returned to the global workforce’. Furthermore, the Innovation Forum, sponsored by the Bill and Melinda Gates Foundation and the US National Institutes of Health recently published the ‘Women’s Health Innovation Opportunity Map 2023’, whilst Roche Pharmaceuticals provided their insights into the business case for women’s health... Continue reading

Industry Insight

Talent Partner | The Bowdoin Group

Women’s Health Beyond Fertility: Breaking the Stigma

As an industry, Women's Health has made huge leaps and bounds in recent years. Yet, it's still mostly viewed through the lens of fertility and maternity. This article offers an exploration into how Women's Health can move beyond that, covering topics of investment, diversity and equitable care.

Read more

With thanks to our Partner:

Bowdoin_Logo_Color

Updates from our Network

42 Technology

The female experience in medical device development - do surgical tools need a redesign?

It’s well known that medical devices have not always addressed female users’ needs. Could devices be improved by taking a fresh look at the female patients or clinicians using them?

Peli Health

Femtech’s untapped potential is a trillion-dollar wakeup call to investors

Femtech, revolutionizing women's health for nearly 4 billion globally, anticipates a $1.186 trillion market by 2027, transcending niche status.

Labiotech

Swedish company develops first effective treatment for hypothyroidism

Prolevi Bio has developed a technology intended to help the 10 to 20% of people who don’t respond to current treatments for underactive thyroid glands. 

FemHealth Insights

Women's Health Innovation Summit: Navigating the Path to Change

Jillian Levovitz, MBA, Chief Executive Officer of FemHealth Insights attends WHIS USA and shares her experience.

Tulipon

A New Technology Turning The Biblical Eve’s Curse Into A Blessing

Hilla Shaviv explores a revolutionary new product that will help you track your menstrual health, as well as act as a more effective tampon, the Tulipon! 

Sifted

Turing Biosystems named “one to watch” by VCs

Turing Biosystems has been included in a list of drug development startups to watch compiled by Sifted.eu. We were named by Leigh Brody, life sciences investor with AlbionVC.

Coyote Ventures

Maternal Mental Health – A National Crisis

In this article, the Coyote Ventures team digs into research on the maternal mental health crisis and highlights 19 digital health start-ups who have made this their mission.

Alpha3 Cloud

Alpha3 Cloud

Alpha3 Cloud’s Journey into Women’s Health Technology

Ron Sacks reflects on his journey into the women's health market and discusses the transformative partnerships, personal revelations, and technological innovations in the space.

Resources & Events

FemInnovation: Building a Winning Sales Mindset in Femtech

Listen here

Opportunity: Springboard's Women's Health Innovation Program. 

Learn More

Podcast: How to Choose a Primary Care Provider

Listen here

Whitepaper: Empathy in the design and development of women’s health technology

Access here

Case Study: Technical due diligence & FMEA of FemTech point-of-care device. 

Learn More

Whitepaper: What Is Femtech and Where Is It Going?

Read More

Whitepaper: Optimizing Your User Experience and Interface for Female Customers 

Access Here

Event: Reproductive Health Innovation Summit 2024

Learn More

LinkedIn
Instagram

Kisaco Research, 41a Maltby Street, London, SE1 3PA

Unsubscribe Manage preferences